Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer

201486 citationsJournal Article

Authors

Good health and well-being

Published in: Cancer Chemotherapy and Pharmacology

Volume 73, Issue 5, pp. 1079-1087

Field-Weighted Citation Impact: 3.72